+987.9%
MRNA vs EMB
+0.7%
+987.2%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | EMB | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +1.0% | +12.1% | +6.4% |
| 7D | +20.6% | +0.7% | +19.9% | +15.6% |
| 30D | +27.1% | +2.3% | +24.8% | +8.4% |
| 3M | +353.4% | -2.5% | +355.9% | +456.4% |
| 6M | +446.3% | -1.1% | +447.4% | +540.6% |
| YTD | +776.2% | -0.6% | +776.8% | +946.9% |
| 1Y | +987.9% | +0.6% | +987.3% | +1,042.8% |
| All | +987.9% | +0.7% | +987.2% | +1,042.8% |
Cumulative growth
Daily Returns
Daily percentage return beside EMB.
Daily Out/Under-Performance
Portfolio return minus EMB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EMB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded EMB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling